Dumadaug, Eriberto F.
HRN: 21-56-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2022
CEFTAZIDIME 1GM (VIAL)
06/18/2022
06/25/2022
IV
1 Gram
Q8hours
CAP MR With Concomittant PTB, Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes